Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.21.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Operating Activities    
Net Loss $ (5,534,340) $ (7,459,254)
Adjustments to reconcile net loss from operations to net cash used in operating activities:    
Common stock issued for services 45,000 17,000
Stock-based compensation 300,583 8,110
Patent write-offs 0 111,850
Changes in operating working capital items:    
Other receivables (110,000) 400,000
Prepaid expenses and other current assets (74,751) (117,281)
Accounts payable and accrued liabilities 780,425 1,465,492
Accrued legal settlement costs (4,200,000) 0
Net Cash Used in Operating Activities (8,793,083) (5,574,083)
Investing Activities    
Patents and trademarks (16,021) (138,692)
Net Cash Used in Investing Activities (16,021) (138,692)
Financing Activities    
Net proceeds from issuances of common stock and exercise of stock options 3,411,091 5,164,685
Net Cash Provided by Financing Activities 3,411,091 5,164,685
Net Decrease in Cash and Cash Equivalents (5,398,013) (548,090)
Cash and Cash Equivalents, Beginning of Period 21,531,665 17,958,989
Cash and Cash Equivalents, End of Period 16,133,652 17,410,899
Supplemental Disclosure of Cash Flow Information:    
Interest paid 0 0
Income taxes paid 0 0
Non-Cash Financing Activities:    
Accumulated preferred stock dividend 575,049 548,637
Conversion of Series A convertible preferred stock to common stock and payment of paid-in-kind dividends to Series A preferred stockholder 39,885 38,071
Payment of accrued liabilities with common stock $ 69,690 $ 17,000